{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:10:25Z","timestamp":1793797825825,"version":"4.6.1"},"reference-count":70,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,11]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Multiple myeloma (MM) continues to be an incurable malignancy, even with recent therapeutic advancements. Although epigenetic dysregulation at cis-regulatory elements is known to drive disease progression, the complete molecular mechanisms underlying these alterations are poorly understood. Using Assay for Transposase-Accessible Chromatin with high-throughput sequencing analysis combined with the computational footprinting of CD138+ cells from 55 patients with MM, we depicted the dynamic changes in chromatin accessibility during disease progression and identified nuclear respiratory factor 1 (NRF1) as a master regulator of vital MM survival pathways. We demonstrated that NRF1 maintains proteasome homeostasis by orchestrating the ubiquitination pathway, which is essential for MM cell survival. We discovered a novel enhancer element that physically interacts with the NRF1 promoter, sustaining its expression. Targeting this enhancer RNA reduced NRF1 levels and increased tumor cell sensitivity to bortezomib (BTZ), suggesting therapeutic potential. In xenograft models, we showed that antisense oligonucleotides targeting the NRF1 enhancer, either alone or combined with BTZ, significantly decreased tumor burden and improved survival. Our findings reveal a previously unknown NRF1-dependent mechanism regulating MM cell survival and present a promising therapeutic approach through the manipulation of its regulatory network.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025028441","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T17:18:13Z","timestamp":1757351893000},"page":"2945-2962","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy"],"prefix":"10.1182","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0352-4523","authenticated-orcid":false,"given":"Tiziana","family":"Bruno","sequence":"first","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9040-005X","authenticated-orcid":false,"given":"Maria Chiara","family":"Cappelletto","sequence":"additional","affiliation":[{"name":"2Microbiology and Virology Unit, Clinic and Dermatology Research Department, San Gallicano Dermatological Institute IRCCS, Rome, Italy"},{"name":"3Charles Darwin Department of Biology and Biotechnologies Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9017-6373","authenticated-orcid":false,"given":"Clelia","family":"Cortile","sequence":"additional","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"},{"name":"3Charles Darwin Department of Biology and Biotechnologies Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2484-7308","authenticated-orcid":false,"given":"Stefano","family":"Di Giovenale","sequence":"additional","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"},{"name":"4Department of Computer, Control and Management Engineering, Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Amadio","sequence":"additional","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Nicola","sequence":"additional","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2796-0792","authenticated-orcid":false,"given":"Italia","family":"Falcone","sequence":"additional","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9905-7870","authenticated-orcid":false,"given":"Stefano","family":"Giuliani","sequence":"additional","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-0113","authenticated-orcid":false,"given":"Belinda","family":"Palermo","sequence":"additional","affiliation":[{"name":"5Tumor Immunology and Immunotherapy Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Catena","sequence":"additional","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7964-7119","authenticated-orcid":false,"given":"Ludovica","family":"Ciuffreda","sequence":"additional","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia","family":"Cerruti","sequence":"additional","affiliation":[{"name":"6Department of Veterinary Sciences, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cascio","sequence":"additional","affiliation":[{"name":"6Department of Veterinary Sciences, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Merola","sequence":"additional","affiliation":[{"name":"7Clinical Pathology Unit, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Masi","sequence":"additional","affiliation":[{"name":"7Clinical Pathology Unit, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"De Pascale","sequence":"additional","affiliation":[{"name":"8Translational Oncology Research Unit, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3095-5313","authenticated-orcid":false,"given":"Ombretta","family":"Annibali","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ferraro","sequence":"additional","affiliation":[{"name":"10Hematology Unit, Department of Hematology, St. Eugenio Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana","family":"Gumenyuk","sequence":"additional","affiliation":[{"name":"11Hematology and Stem Cell Transplant Unit, Clinical and Research Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6853-5605","authenticated-orcid":false,"given":"Francesco","family":"Pisani","sequence":"additional","affiliation":[{"name":"11Hematology and Stem Cell Transplant Unit, Clinical and Research Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marchesi","sequence":"additional","affiliation":[{"name":"11Hematology and Stem Cell Transplant Unit, Clinical and Research Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-2467","authenticated-orcid":false,"given":"Andrea","family":"Mengarelli","sequence":"additional","affiliation":[{"name":"11Hematology and Stem Cell Transplant Unit, Clinical and Research Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5281-4191","authenticated-orcid":false,"given":"Maurizio","family":"Fanciulli","sequence":"additional","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6170-9780","authenticated-orcid":false,"given":"Giacomo","family":"Corleone","sequence":"additional","affiliation":[{"name":"1Gene Expression and Cancer Models Unit, Department of Research and Advanced Technologies Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2025121111221280900_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mayocp.2015.11.007","article-title":"Multiple myeloma: diagnosis and treatment","volume":"91","author":"Rajkumar","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"2025121111221280900_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrc.2017.63","article-title":"Evolutionary biology of high-risk multiple myeloma","volume":"17","author":"Pawlyn","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"2025121111221280900_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"issue":"21","key":"2025121111221280900_bib4","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1182\/blood-2011-01-270140","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies","volume":"117","author":"Korde","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2025121111221280900_bib5","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1038\/s41467-024-50910-z","article-title":"Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma","volume":"15","author":"Xiong","year":"2024","journal-title":"Nat Commun"},{"issue":"20","key":"2025121111221280900_bib6","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2014-11-568881","article-title":"Pathogenesis beyond the cancer clone(s) in multiple myeloma","volume":"125","author":"Bianchi","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2025121111221280900_bib7","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1038\/s41467-021-25704-2","article-title":"Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma","volume":"12","author":"Alvarez-Benayas","year":"2021","journal-title":"Nat Commun"},{"issue":"13","key":"2025121111221280900_bib8","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1182\/blood.2021014391","article-title":"Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma","volume":"139","author":"Trasanidis","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2025121111221280900_bib9","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/s41467-024-46728-4","article-title":"Aberrant non-canonical NF-\u03baB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma","volume":"15","author":"Ang","year":"2024","journal-title":"Nat Commun"},{"issue":"9","key":"2025121111221280900_bib10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1101\/gr.265520.120","article-title":"Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma","volume":"30","author":"Ordonez","year":"2020","journal-title":"Genome Res"},{"issue":"1","key":"2025121111221280900_bib11","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1038\/s41467-024-47793-5","article-title":"Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes","volume":"15","author":"Binder","year":"2024","journal-title":"Nat Commun"},{"issue":"8","key":"2025121111221280900_bib12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S1470-2045(24)00282-1","article-title":"Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial","volume":"25","author":"Moreau","year":"2024","journal-title":"Lancet Oncol"},{"issue":"4","key":"2025121111221280900_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMoa2312054","article-title":"Daratumumab, bortezomib, lenalidomide, and dexamethasone for multiple myeloma","volume":"390","author":"Sonneveld","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"2025121111221280900_bib14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/blood-2012-04-403733","article-title":"Proteasome inhibitors in multiple myeloma: 10 years later","volume":"120","author":"Moreau","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2025121111221280900_bib15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/1535-7163.MCT-12-0782","article-title":"Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma","volume":"12","author":"Vincenz","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"2025121111221280900_bib16","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1182\/blood-2008-08-172734","article-title":"The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition","volume":"113","author":"Bianchi","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2025121111221280900_bib17","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","article-title":"Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition","volume":"67","author":"Meister","year":"2007","journal-title":"Cancer Res"},{"key":"2025121111221280900_bib18","doi-asserted-by":"crossref","first-page":"973836","DOI":"10.3389\/fonc.2022.973836","article-title":"Drug resistance in multiple myeloma: soldiers and weapons in the bone marrow niche","volume":"12","author":"Solimando","year":"2022","journal-title":"Front Oncol"},{"key":"2025121111221280900_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ctrv.2018.09.001","article-title":"Drug resistance in multiple myeloma","volume":"70","author":"Robak","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"2025121111221280900_bib20","doi-asserted-by":"crossref","first-page":"e202306150","DOI":"10.1083\/jcb.202306150","article-title":"Transcription factor Nrf1 regulates proteotoxic stress-induced autophagy","volume":"223","author":"Ward","year":"2024","journal-title":"J Cell Biol"},{"issue":"1","key":"2025121111221280900_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1196\/annals.1427.006","article-title":"Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator","volume":"1147","author":"Scarpulla","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"16","key":"2025121111221280900_bib22","doi-asserted-by":"crossref","first-page":"e113258","DOI":"10.15252\/embj.2022113258","article-title":"NRF1-mediated mitochondrial biogenesis antagonizes innate antiviral immunity","volume":"42","author":"Zhao","year":"2023","journal-title":"EMBO J"},{"issue":"12a","key":"2025121111221280900_bib23","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1101\/gad.7.12a.2431","article-title":"NRF-1, an activator involved in nuclear-mitochondrial interactions, utilizes a new DNA-binding domain conserved in a family of developmental regulators","volume":"7","author":"Virbasius","year":"1993","journal-title":"Genes Dev"},{"issue":"14","key":"2025121111221280900_bib24","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1073\/pnas.1032913100","article-title":"Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1","volume":"100","author":"Patti","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"2025121111221280900_bib25","doi-asserted-by":"crossref","first-page":"69477","DOI":"10.18632\/oncotarget.17704","article-title":"BRAF\/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"2025121111221280900_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13046-016-0324-0","article-title":"Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study","volume":"35","author":"Cordone","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"issue":"W1","key":"2025121111221280900_bib27","doi-asserted-by":"crossref","first-page":"W171","DOI":"10.1093\/nar\/gkz365","article-title":"CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing","volume":"47","author":"Labun","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2025121111221280900_bib28","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nmeth.2688","article-title":"Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position","volume":"10","author":"Buenrostro","year":"2013","journal-title":"Nat Methods"},{"issue":"10","key":"2025121111221280900_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nmeth.3542","article-title":"ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors","volume":"12","author":"Schmidl","year":"2015","journal-title":"Nat Methods"},{"issue":"14","key":"2025121111221280900_bib30","first-page":"1754","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"16","key":"2025121111221280900_bib31","first-page":"2078","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"9","key":"2025121111221280900_bib32","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol"},{"issue":"17","key":"2025121111221280900_bib33","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/bioinformatics\/btq351","article-title":"BigWig and BigBed: enabling browsing of large distributed datasets","volume":"26","author":"Kent","year":"2010","journal-title":"Bioinformatics"},{"issue":"6","key":"2025121111221280900_bib34","first-page":"841","article-title":"BEDTools: a flexible suite of utilities for comparing genomic features","volume":"26","author":"Quinlan","year":"2010","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"9","key":"2025121111221280900_bib35","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s41591-018-0091-x","article-title":"Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer","volume":"24","author":"Patten","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"2025121111221280900_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13046-024-03075-y","article-title":"Enhancer engagement sustains oncogenic transformation and progression of B-cell precursor acute lymphoblastic leukemia","volume":"43","author":"Corleone","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"19","key":"2025121111221280900_bib37","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood-2017-09-808063","article-title":"Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma","volume":"131","author":"Jin","year":"2018","journal-title":"Blood"},{"issue":"7858","key":"2025121111221280900_bib38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41586-021-03446-x","article-title":"Genome-wide enhancer maps link risk variants to disease genes","volume":"593","author":"Nasser","year":"2021","journal-title":"Nature"},{"issue":"6413","key":"2025121111221280900_bib39","doi-asserted-by":"crossref","first-page":"eaav1898","DOI":"10.1126\/science.aav1898","article-title":"The chromatin accessibility landscape of primary human cancers","volume":"362","author":"Corces","year":"2018","journal-title":"Science"},{"issue":"5","key":"2025121111221280900_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccell.2020.08.020","article-title":"A high-resolution map of human enhancer RNA loci characterizes super-enhancer activities in cancer","volume":"38","author":"Chen","year":"2020","journal-title":"Cancer Cell"},{"issue":"7201","key":"2025121111221280900_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"issue":"6","key":"2025121111221280900_bib42","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41375-018-0036-x","article-title":"Targeting MYC in multiple myeloma","volume":"32","author":"Jovanovi\u0107","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"2025121111221280900_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18632\/oncotarget.109","article-title":"A critical role for the NFkB pathway in multiple myeloma","volume":"1","author":"Demchenko","year":"2010","journal-title":"Oncotarget"},{"issue":"1","key":"2025121111221280900_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41467-021-27666-x","article-title":"Functional dissection of inherited non-coding variation influencing multiple myeloma risk","volume":"13","author":"Ajore","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"2025121111221280900_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2008.01.007","article-title":"AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies","volume":"13","author":"Chesi","year":"2008","journal-title":"Cancer Cell"},{"issue":"22","key":"2025121111221280900_bib46","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1182\/bloodadvances.2020002566","article-title":"Che-1\/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma","volume":"4","author":"Bruno","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"2025121111221280900_bib47","doi-asserted-by":"crossref","first-page":"e202302195","DOI":"10.26508\/lsa.202302195","article-title":"Exploring the impact of dexamethasone on gene regulation in myeloma cells","volume":"6","author":"Bessonneau-Gaborit","year":"2023","journal-title":"Life Sci Alliance"},{"issue":"12","key":"2025121111221280900_bib48","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1038\/nprot.2017.124","article-title":"Chromatin-state discovery and genome annotation with ChromHMM","volume":"12","author":"Ernst","year":"2017","journal-title":"Nat Protoc"},{"issue":"4","key":"2025121111221280900_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrg.2016.4","article-title":"Enhancers as non-coding RNA transcription units: recent insights and future perspectives","volume":"17","author":"Li","year":"2016","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2025121111221280900_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41375-019-0519-4","article-title":"Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination","volume":"34","author":"Akhmetzyanova","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"2025121111221280900_bib51","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1093\/nar\/gkw1220","article-title":"Single-cell profiling reveals that eRNA accumulation at enhancer\u2013promoter loops is not required to sustain transcription","volume":"45","author":"Rahman","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2025121111221280900_bib52","doi-asserted-by":"crossref","first-page":"e1000384","DOI":"10.1371\/journal.pbio.1000384","article-title":"A large fraction of extragenic RNA Pol II transcription sites overlap enhancers","volume":"8","author":"De Santa","year":"2010","journal-title":"PLoS Biol"},{"issue":"14","key":"2025121111221280900_bib53","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1182\/blood-2009-12-261032","article-title":"Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients","volume":"116","author":"Broyl","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2025121111221280900_bib54","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"Zhan","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2025121111221280900_bib55","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/s41588-024-01853-0","article-title":"Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes","volume":"56","author":"Skerget","year":"2024","journal-title":"Nat Genet"},{"issue":"8","key":"2025121111221280900_bib56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2016.62","article-title":"The unfolded protein response in immunity and inflammation","volume":"16","author":"Grootjans","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"14","key":"2025121111221280900_bib57","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1073\/pnas.94.14.7156","article-title":"Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation","volume":"94","author":"Arendt","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2025121111221280900_bib58","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0092-8674(00)80171-3","article-title":"Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly","volume":"86","author":"Chen","year":"1996","journal-title":"Cell"},{"issue":"2","key":"2025121111221280900_bib59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.hoc.2023.12.016","article-title":"Proteasome inhibitors in multiple myeloma biological insights on mechanisms of action or resistance informed by functional genomics","volume":"38","author":"Mitsiades","year":"2024","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"2025121111221280900_bib60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/bloodadvances.2020003820","article-title":"Multiple myeloma cells depend on the DDI2\/NRF1-mediated proteasome stress response for survival","volume":"6","author":"Chen","year":"2022","journal-title":"Blood Adv"},{"issue":"5","key":"2025121111221280900_bib61","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41419-022-04925-3","article-title":"The aspartyl protease DDI2 drives adaptation to proteasome inhibition in multiple myeloma","volume":"13","author":"Op","year":"2022","journal-title":"Cell Death Dis"},{"issue":"11","key":"2025121111221280900_bib62","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting transcription factors in cancer \u2013 from undruggable to reality","volume":"19","author":"Bushweller","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"28","key":"2025121111221280900_bib63","doi-asserted-by":"crossref","first-page":"16292","DOI":"10.1073\/pnas.1922606117","article-title":"Pharmacological disruption of the Notch transcription factor complex","volume":"117","author":"Lehal","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2025121111221280900_bib64","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.chembiol.2019.02.009","article-title":"Stabilization of the Max homodimer with a small molecule attenuates Myc-driven transcription","volume":"26","author":"Struntz","year":"2019","journal-title":"Cell Chem Biol"},{"issue":"6168","key":"2025121111221280900_bib65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"issue":"9","key":"2025121111221280900_bib66","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","article-title":"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity","volume":"32","author":"Amodio","year":"2018","journal-title":"Leukemia"},{"issue":"16","key":"2025121111221280900_bib67","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1182\/blood.2023021991","article-title":"An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma","volume":"144","author":"Grillone","year":"2024","journal-title":"Blood"},{"issue":"7583","key":"2025121111221280900_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature16462","article-title":"Competition between DNA methylation and transcription factors determines binding of NRF1","volume":"528","author":"Domcke","year":"2015","journal-title":"Nature"},{"issue":"1","key":"2025121111221280900_bib69","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1038\/s41467-020-18035-1","article-title":"ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation","volume":"11","author":"Bentsen","year":"2020","journal-title":"Nat Commun"},{"issue":"D1","key":"2025121111221280900_bib70","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/24\/2945\/2471167\/blood_bld-2025-028441-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/24\/2945\/2471167\/blood_bld-2025-028441-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T16:22:27Z","timestamp":1765470147000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/24\/2945\/547147\/Nuclear-respiratory-factor-1-promotes-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":70,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025,12,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025028441","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,11]]},"published":{"date-parts":[[2025,12,11]]}}}